MIRAMAR, Fla., Nov. 13, 2019 (GLOBE NEWSWIRE) -- G
Post# of 36537
(Total Views: 290)
Posted On: 11/13/2019 2:09:54 PM
MIRAMAR, Fla., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation(GNBT) (www.generex.com) today announced that it will hold an investor conference call on Friday November 29, 2019 at 9:30 am.
Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.” This call will cover the newly paid 1:1 dividend, our new spin out to the public of NuGenerex Immuno-oncology and the new proposed dividend to Generex shareholders of this company and the closing of the Altucell acquisition closing, as well as other corporate initiatives that are ongoing such as our Nasdaq listing which is still in process.
Dial-in instructions for the investor conference call will be announced prior to the meeting date.
Joseph Moscato, Generex President & Chief Executive Officer stated: “I look forward to this conference call and invite all of our valuable shareholders to attend.” This call will cover the newly paid 1:1 dividend, our new spin out to the public of NuGenerex Immuno-oncology and the new proposed dividend to Generex shareholders of this company and the closing of the Altucell acquisition closing, as well as other corporate initiatives that are ongoing such as our Nasdaq listing which is still in process.
Dial-in instructions for the investor conference call will be announced prior to the meeting date.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼